Genentech’s Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by 30% in ER-positive Early-Stage Breast Cancer

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive data from the Phase III lidERA Breast Cancer study evaluating investigational giredestrant as an adjuvant ...
Goldseiten

Seabridge Gold Continues to Expand Snip North Deposit

Seabridge Gold today announced further results from 2025 drilling on the Snip North Deposit at the 100% owned Iskut project. Each hole intersected wide intervals of consistent and continuous gold and ...

College football bowl confidence pools 2025-26: Picks, predictions, optimal rankings by proven expert

So before filling out your college football pool picks or making any college football bets, you need to see Casale's college ...

Doubleview Extends High-Grade Domains at Hat: H099 Returns 438m of 0.40% CuEq Including 52m of 1.02% CuEq, Expanding Mineralization Envelope Around Conceptual Pit Vertically ...

Detailed price information for Doubleview Gold Corp (DBG-X) from The Globe and Mail including charting and trades.

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian ...

Johnson & Johnson today announced final overall survival (OS) results from the Asia patients of the Phase 3 MARIPOSA study. Head-to-head comparison data versus osimertinib monotherapy showed ...